Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner?
@article{TCR100059, author = {Priyanka Bhateja and Marcelo Bonomi and Claire Verschraegen}, title = {Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner?}, journal = {Translational Cancer Research}, volume = {0}, number = {0}, year = {2025}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/100059} }